BNGO - バイオナノ・ジェノミクス (Bionano Genomics Inc.) バイオナノ・ジェノミクス

 BNGOのチャート


 BNGOの企業情報

symbol BNGO
会社名 BioNano Genomics Inc (バイオナノ・ジェノミクス)
分野(sector) Capital Goods   資本財(工業製品)
産業(industry) Biotechnology: Laboratory Analytical Instruments  
業種 先端医療機器_テクノロジ―   IT・通信(IT_Communications)
概要 事業概要 Bionano Genomics Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone however is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.   バイオナノ・ジェノミクスは米国の計測機器メ―カ―。主にゲノム解析のライフサイエンス研究に使用される計測機器の製造・販売に従事する。研究者および臨床医が染色体の変化を研究し、超高感度で特異的な構造変化が検出できるプラットフォ―ム「Saphyr」システムを開発。同システムは検出機器、チップ、試薬と解析ツ―ルで構成。本社はカリフォルニア州サンディエゴ。   
本社所在地 9640 Towne Centre Drive Suite 100 San Diego CA 92121 USA
代表者氏名 David L. Barker デヴィッド・L・バーカー
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 858-888-7600
設立年月日
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数
url www.bionanogenomics.com
nasdaq_url https://www.nasdaq.com/symbol/bngo
adr_tso
EBITDA EBITDA(百万ドル) -16.45547
終値(lastsale) 6.5325
時価総額(marketcap) 62002779.54
時価総額 時価総額(百万ドル) 65.87054
売上高 売上高(百万ドル) 10.74668
企業価値(EV) 企業価値(EV)(百万ドル) 124.54237
当期純利益 当期純利益(百万ドル) -18.16421
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 BioNano Genomics Inc revenues increased 32% to $5.2M. Net loss decreased 42% to $7.2M. Revenues reflect EMEA segment increase of 27% to $1M Northern America segment increase of 6% to $1.9M. Lower net loss reflects Research and development decrease of 32% to $4.5M (expense) Other Non Operating I/E increase from $954K to $2.5M (income).

 BNGOのテクニカル分析


 BNGOのニュース

   Maxim Group Stick to Their Buy Rating for BioNano Genomics Inc By Investing.com  2021/03/25 11:37:30 Investing.com
Maxim Group Stick to Their Buy Rating for BioNano Genomics Inc
   Investing in Rapidly Growing Autism Therapy Market (NASDAQ: BNGO) (OTC US: ISWH) (NASDAQ: ZYNE) - Stocks News Feed  2021/03/19 12:38:36 Stocks News Feed
While it doesn’t get a lot of press, the Autism market is unfortunately a rapidly growing market opportunity. According to recent data from the CDC, roughly 2% of all kids are now diagnosed with Autism Spectrum Disorder (ASD). That number is up from 0.1% just two decades ago. This staggering rise has led to a… Read More »Investing in Rapidly Growing Autism Therapy Market (NASDAQ: BNGO) (OTC US: ISWH) (NASDAQ: ZYNE)
   Investing in Rapidly Growing Autism Therapy Market (NASDAQ: BNGO) (OTC US: ISWH) (NASDAQ: ZYNE)  2021/03/19 11:53:39 MarketWatch
Mar 19, 2021 (OTC PR WIRE via COMTEX) -- While it doesn't get a lot of press, the Autism market is unfortunately a rapidly growing market opportunity….
   Earnings Scorecard & Analyst Reports for NASDAQ:BNGO NASDAQ:TRVN NASDAQ:GOCO NASDAQ:FLL and #Covid-19 (#Coronavirus) impact  2021/03/12 21:35:00 Stock Market Daily
Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest
   Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies?  2021/03/10 13:30:00 PR Newswire
NEW YORK, March 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Earnings Scorecard & Analyst Reports for NASDAQ:BNGO NASDAQ:TRVN NASDAQ:GOCO NASDAQ:FLL and #Covid-19 (#Coronavirus) impact  2021/03/12 21:35:00 Stock Market Daily
Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest
   Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies?  2021/03/10 13:30:00 PR Newswire
NEW YORK, March 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Why Bionano Genomics (BNGO) Might Surprise This Earnings Season  2021/03/05 13:53:01 Yahoo Finance
Bionano Genomics (BNGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
   BNGO Stock Price: BioNano Genomics Inc may provide buying opportunity with a potential Wednesday dip  2021/02/17 07:55:00 FXStreet
Is the strain a stain on a country's image – the world's approach is changing from one that is fearful of COVID-19 variants to one that appreciates co
   Why Bionano Genomics Stock Is Trading Higher Today  2021/02/12 14:51:00 Benzinga
Bionano Genomics (NASDAQ: BNGO) shares are trading higher Friday after the company tweeted about an upcoming webinar. Bionano Genomics tweeted, …
   BNGO Stock Price: BioNano Genomics Inc may provide buying opportunity with a potential Wednesday dip  2021/02/17 07:55:00 FXStreet
Is the strain a stain on a country's image – the world's approach is changing from one that is fearful of COVID-19 variants to one that appreciates co
   Why Bionano Genomics Stock Is Trading Higher Today  2021/02/12 14:51:00 Benzinga
Bionano Genomics (NASDAQ: BNGO) shares are trading higher Friday after the company tweeted about an upcoming webinar. Bionano Genomics tweeted, …
   Maxim Group Stick to Their Buy Rating for BioNano Genomics Inc By Investing.com  2021/02/09 09:07:46 Investing.com
Maxim Group Stick to Their Buy Rating for BioNano Genomics Inc
   Oppenheimer Stick to Their Buy Rating for BioNano Genomics Inc By Investing.com  2021/02/07 23:35:02 Investing.com
Oppenheimer Stick to Their Buy Rating for BioNano Genomics Inc
   Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know  2021/02/03 22:45:10 Yahoo Finance
Bionano Genomics, Inc. (BNGO) closed at $11.85 in the latest trading session, marking a -1.41% move from the prior day.

 関連キーワード  (先端医療機器_テクノロジ― 米国株 バイオナノ・ジェノミクス BNGO Bionano Genomics Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)